The Coxsackie B Viruses

1. Front Matter

   Pages i-x

   PDF

2. A Short History and Introductory Background on the Coxsackieviruses of Group B

   • R. L. Crowell, B. J. Landau

   Pages 1-11

3. Coxsackievirus B Epidemiology and Public Health Concerns

   • M. A. Pallansch

   Pages 13-30

4. Coxsackie B Viruses and Human Heart Disease

   • C. Baboonian, M. J. Davies, J. C. Booth, W. J. McKenna

   Pages 31-52

5. Group B Coxsackie Disease in Children

   • J. F. Modlin, H. A. Rotbart

   Pages 53-80

6. Effects of Nutritional Antioxidants and Other Dietary Constituents on Coxsackievirus-Induced Myocarditis

   • M. A. Beck, O. A. Levander

   Pages 81-96

7. Genetic Divergence Among the Group B Coxsackieviruses

   • J. R. Romero, C. Price, J. J. Dunn

   Pages 97-152

8. Coxsackievirus B5 and the Relationship to Swine Vesicular Disease Virus

   • N. J. Knowles, J. W. McCauley

   Pages 153-167

9. Higher Order Structures of Coxsackievirus B 5’ Nontranslated Region RNA

   • K. M. Currey, B. A. Shapiro

   Pages 169-190

10. The Structure of Coxsackievirus B3

    • J. K. Muckelbauer, M. G. Rossmann

    Pages 191-208

11. Identification and Biology of Cellular Receptors for the Coxsackie B Viruses Group

    • R. J. Kuhn

    Pages 209-226

12. Genetics of Coxsackievirus Virulence

    • N. M. Chapman, A. I. Ramsingh, S. Tracy

    Pages 227-258

13. Roles of the Humoral Response in Coxsackievirus B-Induced Disease

    • C. J. Gauntt

    Pages 259-282

14. Roles of T Cells in Coxsackievirus B-Induced Disease

    • P. L. Schwimmbeck, S. A. Huber, H.-P. Schultheiss

    Pages 283-303

15. Back Matter

    Pages 305-311

    PDF

S. TRACY Late in the 1940s, a virus was isolated from a young patient with a flaccid par­ alysis in the sleepy Hudson River town of Coxsackie in the state of New York. Within the next few years, it was apparent that this and other similar viruses were not polioviruses but were indeed a new group of viruses, viruses that by the mid- 1950s had been found to be commonly associated with pediatric inflammatory heart disease. Two groups of coxsackieviruses (A and B) were differentiated on the basis of the type of paralysis induced in suckling mice by these viruses. Group B coxsackieviruses, because of their primacy as etiologic agents of human acute viral myocarditis and its relatively common sequela, dilated cardiomyopathy, are the focus of this volume. of the century approaches, the massive international effort to eradi­ As the end cate polioviruses through vaccination as causes of human disease has been success­ ful in the Western Hemisphere and in many parts of Europe, and it is expected that worldwide eradication may be achieved within the near future. While this is wonderful news, there are sadly no similar efforts being planned to combat the numerous other human enteroviruses that daily incur widespread morbidity and mortality throughout the world. While this is due in part to the lack of specific know­ ledge about the other human enteroviruses, it is also due to the perceptions of industry that there is insufficient profit to be made by developing these vaccines.

• Eneroviren
• Picornaviren
• RNA
• Viren
• Viren (Coxsackievirus)
• cardiology
• coxsacievirus
• coxsackie b virus
• diseases
• genetics
• heart
• infection
• infections
• picornavirus
• virus

• Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, USA

  Steven Tracy, Nora M. Chapman

• National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, USA

  Brian W. J. Mahy

Policies and ethics